The anti-mRNA sentiment — coupled with the sweeping shake-up of science funding across the United States — has sparked fears ...

As the field of personalized medicine evolves, digital technologies are playing a central role in revolutionizing cancer ...

Company aims to develop a bird flu vaccine with rapid mass production and variant responsiveness. SK bioscience and KDCA join ...

FRIDAY, April 25, 2025 (HealthDay News) -- On Tuesday, the U.S. Department of Health and Human Services announced that the ...

Novavax faces uncertainty as FDA requests a new clinical trial for its COVID-19 vaccine, the last protein-based option in the ...

Clinical trials for the NIH's new universal flu vaccine are anticipated by 2026, with FDA approval by 2029. Other viruses ...

The nasal vaccine, tested on animals since 2021, may offer a new tool in fighting COVID-19 with a non-invasive, ...

mRNA vaccines offer clear advantages and disadvantages ... candidates for seasonal influenza and COVID-19 in Phase 2 and avian influenza in Phase 1 clinical development. Sanofi is developing ...

We recently published a list of the 11 Worst Performing Stocks in S&P 500 So Far in 2025. In this article, we will take a ...

Avian influenza A(H5N1), commonly known as ... Moderna is currently in the very early stages of testing a bird flu vaccine using the same mRNA technology that allowed for rapid development and ...